v3.26.1
Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Consolidated Statements of Operations [Abstract]        
Revenue $ 0 $ 0 $ 0 $ 0
Operating expenses:        
Research and development 29,497 42,658 60,951 78,600
General and administrative 17,425 25,020 34,482 53,466
Restructuring 0 3,471 0 3,471
Total operating expenses 46,922 71,149 95,433 135,537
Loss from operations (46,922) (71,149) (95,433) (135,537)
Gain from sale of PRV 178,190 0 178,190 0
Interest expense (473) (473) (946) (945)
Interest and other income, net 347 483 508 1,819
Accretion of discount on investments, net 693 2,220 1,922 4,410
Earnings (losses) before Income Taxes 131,835 (68,919) 84,241 (130,253)
Provision for Income Taxes (8,621) 0 (8,621) 0
Net income (loss) $ 123,214 $ (68,919) $ 75,620 $ (130,253)
Net income (loss) per share - basic (in dollars per share) $ 1.09 $ (0.62) $ 0.67 $ (1.18)
Net income (loss) per share - diluted (in dollars per share) $ 1.08 $ (0.62) $ 0.66 $ (1.18)
Weighted-average common shares outstanding - basic (in shares) 112,844,880 111,019,647 112,491,433 110,559,113
Weighted-average common shares outstanding - diluted (in shares) 114,513,964 111,019,647 114,329,763 110,559,113